• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉血栓形成与非肝移植肝硬化患者生存的相关性:文献系统评价。

Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature.

机构信息

Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang 110840, China ; Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, China.

Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang 110840, China.

出版信息

Gastroenterol Res Pract. 2015;2015:480842. doi: 10.1155/2015/480842. Epub 2015 Feb 24.

DOI:10.1155/2015/480842
PMID:25810714
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4355112/
Abstract

A systematic review of the literature was performed to analyze the association between portal vein thrombosis (PVT) and survival in non-liver-transplant patients with liver cirrhosis. PubMed, EMBASE, and Cochrane Library databases were searched for all relevant papers which evaluated the prognostic value of PVT in predicting the survival of liver cirrhosis. Meta-analyses were not conducted because the ways of data expression and lengths of follow-up were heterogeneous among studies. Overall, 13 papers were included. The 5-day, 6-week, and 1-year mortality were investigated in 1, 3, and 1 studies, respectively; and all of them were not significantly different between cirrhotic patient with and without PVT. By comparison, the 3-year mortality was reported in 1 study; and it was significantly increased by the presence of PVT. The overall mortality was analyzed in 5 studies; and the association with overall mortality and PVT was significant in 4 studies, but not in another one. However, as for the cirrhotic patients undergoing surgical or interventional shunts, the overall mortality was not significantly associated with the presence of PVT in 4 studies. In conclusion, the presence of PVT might be associated with the long-term mortality in non-liver-transplant patients with liver cirrhosis, but not with the short-term mortality.

摘要

系统地回顾了文献,分析了非肝移植肝硬化患者门静脉血栓形成(PVT)与生存率之间的关系。检索了 PubMed、EMBASE 和 Cochrane Library 数据库中所有评估 PVT 预测肝硬化患者生存率的预后价值的相关论文。由于研究之间的数据表达方式和随访时间长短存在异质性,因此未进行荟萃分析。总共纳入了 13 篇论文。分别在 1、3 和 1 项研究中研究了 5 天、6 周和 1 年的死亡率,并且 PVT 阳性和阴性的肝硬化患者之间的死亡率均无显著差异。相比之下,1 项研究报告了 3 年的死亡率,并且 PVT 的存在显著增加了死亡率。5 项研究分析了总体死亡率,其中 4 项研究表明与总体死亡率和 PVT 存在关联,而另一项研究则没有。然而,对于接受手术或介入分流术的肝硬化患者,4 项研究表明 PVT 的存在与总体死亡率无显著关联。总之,PVT 的存在可能与非肝移植肝硬化患者的长期死亡率相关,但与短期死亡率无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdd/4355112/6aac4a3f0868/GRP2015-480842.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdd/4355112/6aac4a3f0868/GRP2015-480842.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcdd/4355112/6aac4a3f0868/GRP2015-480842.001.jpg

相似文献

1
Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature.门静脉血栓形成与非肝移植肝硬化患者生存的相关性:文献系统评价。
Gastroenterol Res Pract. 2015;2015:480842. doi: 10.1155/2015/480842. Epub 2015 Feb 24.
2
Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature.门静脉血栓形成与肝硬化出血风险之间的关联:文献系统综述
Clin Res Hepatol Gastroenterol. 2015 Dec;39(6):683-91. doi: 10.1016/j.clinre.2015.02.012. Epub 2015 May 5.
3
Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: A systematic review and meta-analysis.门静脉血栓形成对未行肝移植的肝硬化患者预后的影响:系统评价和荟萃分析。
Medicine (Baltimore). 2021 Apr 23;100(16):e25439. doi: 10.1097/MD.0000000000025439.
4
Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis.非选择性β受体阻滞剂与肝硬化门静脉血栓形成的相关性:系统评价和荟萃分析。
Hepatol Int. 2019 Jul;13(4):468-481. doi: 10.1007/s12072-019-09951-6. Epub 2019 Jun 7.
5
Association between portal vein thrombosis and survival of liver transplant recipients: a systematic review and meta-analysis of observational studies.门静脉血栓形成与肝移植受者生存率之间的关联:一项观察性研究的系统评价和荟萃分析
J Gastrointestin Liver Dis. 2015 Mar;24(1):51-9, 4 p following 59. doi: 10.15403/jgld.2014.1121.qix.
6
Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis.肝移植受者门静脉血栓形成的死亡率 - 一项更新的荟萃分析。
Transpl Int. 2018 Dec;31(12):1318-1329. doi: 10.1111/tri.13353. Epub 2018 Oct 23.
7
Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.肝硬化和门静脉血栓形成的抗凝治疗是安全的,并可改善晚期肝硬化的预后。
Dig Dis Sci. 2019 Sep;64(9):2671-2683. doi: 10.1007/s10620-019-05572-z. Epub 2019 Mar 9.
8
Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis.D-二聚体在肝硬化门静脉血栓形成中的作用:一项荟萃分析
Saudi J Gastroenterol. 2015 May-Jun;21(3):165-74. doi: 10.4103/1319-3767.157567.
9
Portal Vein Thrombosis Is a Risk Factor for Poor Early Outcomes After Liver Transplantation: Analysis of Risk Factors and Outcomes for Portal Vein Thrombosis in Waitlisted Patients.门静脉血栓形成是肝移植术后早期预后不良的危险因素:对等待名单上患者门静脉血栓形成的危险因素及预后分析
Transplantation. 2016 Jan;100(1):126-33. doi: 10.1097/TP.0000000000000785.
10
Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis.门静脉血栓形成与肝硬化患者的死亡率增加无关。
Clin Gastroenterol Hepatol. 2015 Mar;13(3):585-93. doi: 10.1016/j.cgh.2014.10.010. Epub 2014 Oct 18.

引用本文的文献

1
Missed diagnosis rate of portal venous system thrombosis in cirrhosis on contrast-enhanced CT scans: Review of radiology reports from a tertiary hospital.肝硬化患者门静脉系统血栓形成在增强CT扫描中的漏诊率:来自一家三级医院的放射学报告回顾
Intern Emerg Med. 2025 Aug 18. doi: 10.1007/s11739-025-04076-1.
2
Guidelines for the Management of Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension.肝硬化门静脉高压症食管胃底静脉曲张出血的管理指南
J Clin Transl Hepatol. 2023 Dec 28;11(7):1565-1579. doi: 10.14218/JCTH.2023.00061. Epub 2023 Oct 17.
3
Portal Fibrotic Cord is Associated with Transjugular Intrahepatic Portosystemic Shunt Failure and Death in Cirrhotic Patients.

本文引用的文献

1
Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature.经颈静脉肝内门体分流术治疗门静脉血栓形成:文献综述
Hepatol Int. 2012 Jun;6(3):576-90. doi: 10.1007/s12072-011-9324-5. Epub 2011 Dec 1.
2
Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis.抗磷脂抗体与内脏静脉血栓形成的关联:一项系统评价与荟萃分析
Medicine (Baltimore). 2015 Jan;94(4):e496. doi: 10.1097/MD.0000000000000496.
3
Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.
门静脉纤维化索与肝硬化患者经颈静脉肝内门体分流术失败及死亡相关。
J Clin Transl Hepatol. 2023 Aug 28;11(4):809-816. doi: 10.14218/JCTH.2022.00391. Epub 2023 Jan 4.
4
Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?肝硬化合并门静脉血栓形成患者直接口服抗凝剂的应用:证据有哪些?
World J Hepatol. 2022 Apr 27;14(4):682-695. doi: 10.4254/wjh.v14.i4.682.
5
The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study.门静脉血栓形成对肝硬化患者预后的影响:一项回顾性倾向评分匹配研究
Front Med (Lausanne). 2021 Jun 28;8:685944. doi: 10.3389/fmed.2021.685944. eCollection 2021.
6
Nontumoral Portal Vein Thrombosis: A Challenging Consequence of Liver Cirrhosis.非肿瘤性门静脉血栓形成:肝硬化的一个具有挑战性的后果。
J Clin Transl Hepatol. 2020 Dec 28;8(4):432-444. doi: 10.14218/JCTH.2020.00067. Epub 2020 Nov 11.
7
Controversies in the Management of Portal Vein Thrombosis in Liver Cirrhosis.肝硬化门静脉血栓形成管理中的争议
J Clin Med. 2020 Dec 2;9(12):3916. doi: 10.3390/jcm9123916.
8
Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate.肝硬化门静脉血栓形成:为何一个众所周知的并发症仍存在争议。
World J Gastroenterol. 2019 Aug 21;25(31):4437-4451. doi: 10.3748/wjg.v25.i31.4437.
9
Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants.门静脉血栓形成的管理进展及新型抗凝剂的作用
J Clin Transl Hepatol. 2019 Jun 28;7(2):154-164. doi: 10.14218/JCTH.2018.00057.
10
Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.肝硬化门静脉血栓形成:诊断、自然病程及治疗挑战
Ann Gastroenterol. 2018 May-Jun;31(3):315-329. doi: 10.20524/aog.2018.0245. Epub 2018 Mar 3.
肝硬化门静脉血栓形成治疗的抗凝治疗:观察性研究的系统评价和荟萃分析
Eur J Intern Med. 2015 Jan;26(1):23-9. doi: 10.1016/j.ejim.2014.12.002. Epub 2015 Jan 5.
4
Benefit Stratification of Prophylactic Anticoagulation in Liver Cirrhosis: More Questions Than Answers.肝硬化患者预防性抗凝治疗的获益分层:问题多于答案。
Clin Gastroenterol Hepatol. 2015 Oct;13(10):1856-7. doi: 10.1016/j.cgh.2014.08.023. Epub 2014 Aug 23.
5
Inherited thrombophilia and the risk of portal vein thrombosis: progress toward individualized anticoagulation in cirrhosis?遗传性血栓形成倾向与门静脉血栓形成风险:肝硬化个体化抗凝治疗的进展?
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1813-4. doi: 10.1016/j.cgh.2014.07.040. Epub 2014 Jul 30.
6
Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis.凝血因子 V 莱顿和凝血酶原 G20210A 突变与布加综合征和门静脉血栓形成的关系:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2014 Nov;12(11):1801-12.e7. doi: 10.1016/j.cgh.2014.04.026. Epub 2014 Apr 30.
7
Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd-Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis of observational studies.布加综合征和门静脉血栓形成中的亚甲基四氢叶酸还原酶C677T基因突变与高同型半胱氨酸血症:观察性研究的系统评价和荟萃分析
Hepatol Res. 2014 Dec;44(14):E480-98. doi: 10.1111/hepr.12348. Epub 2014 May 20.
8
Scientific publications on portal vein thrombosis and Budd-Chiari syndrome: a global survey of the literature.关于门静脉血栓形成和布加综合征的科学出版物:文献的全球调查
J Gastrointestin Liver Dis. 2014 Mar;23(1):65-71.
9
Management of portal vein thrombosis in liver cirrhosis.肝硬化门静脉血栓形成的处理。
Nat Rev Gastroenterol Hepatol. 2014 Jul;11(7):435-46. doi: 10.1038/nrgastro.2014.36. Epub 2014 Apr 1.
10
Liver cirrhosis.肝硬化。
Lancet. 2014 May 17;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28.